- Home
- XTNT vs CODA Comparison
XTNT vs CODA Comparison
Compare XTNT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- CODA
- Stock Information
- Founded
- XTNT N/A
- CODA 1994
- Country
- XTNT United States
- CODA United States
- Employees
- XTNT N/A
- CODA N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- CODA Industrial Machinery/Components
- Sector
- XTNT Health Care
- CODA Industrials
- Exchange
- XTNT Nasdaq
- CODA Nasdaq
- Market Cap
- XTNT 89.8M
- CODA 88.8M
- IPO Year
- XTNT N/A
- CODA N/A
- Fundamental
- Price
- XTNT $0.67
- CODA $8.91
- Analyst Decision
- XTNT
- CODA Strong Buy
- Analyst Count
- XTNT 0
- CODA 1
- Target Price
- XTNT N/A
- CODA $11.00
- AVG Volume (30 Days)
- XTNT 104.0K
- CODA 88.9K
- Earning Date
- XTNT 11-11-2025
- CODA 09-15-2025
- Dividend Yield
- XTNT N/A
- CODA N/A
- EPS Growth
- XTNT N/A
- CODA 15.09
- EPS
- XTNT N/A
- CODA 0.30
- Revenue
- XTNT $127,766,000.00
- CODA $24,347,217.00
- Revenue This Year
- XTNT $13.03
- CODA $30.82
- Revenue Next Year
- XTNT N/A
- CODA $20.84
- P/E Ratio
- XTNT N/A
- CODA $28.40
- Revenue Growth
- XTNT 15.16
- CODA 29.34
- 52 Week Low
- XTNT $0.33
- CODA $5.76
- 52 Week High
- XTNT $0.78
- CODA $9.89
- Technical
- Relative Strength Index (RSI)
- XTNT 56.23
- CODA 62.64
- Support Level
- XTNT $0.62
- CODA $7.85
- Resistance Level
- XTNT $0.67
- CODA $8.88
- Average True Range (ATR)
- XTNT 0.04
- CODA 0.40
- MACD
- XTNT 0.00
- CODA 0.05
- Stochastic Oscillator
- XTNT 75.11
- CODA 89.74
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.